Chronic Rhinosinusitis Market 2020 Growth Trends by Manufacturers, Regions, Type and Application, Sales, Ex-factory Price and Forecast to 2027
Market Size – USD 2132.5 Million in 2019, Market Growth – CAGR of 7.4%, Market Trends– growing prevalence of chronic asthma, potential investment opportunities and technological advancements is expected to fuel the market in the forecast period
The
global Chronic Rhinosinusitis Market was valued at USD 2132.5 million in 2019
and is expected to reach USD 3508.0 million by 2027, at a CAGR of 7.4%,
According to the current analysis of Emergen Research. Development and
manufacture of proficient sinusitis drugs are likely to be highly demanded for
efficient treatment of chronic rhinosinusitis as, pollutants, fungal infections
and allergies immensely contribute to the rising incidence of rhinosinusitis.
Moreover, growing prevalence of growing prevalence of chronic asthma,
inflammation of mucosal linings of the nasal passage, and cases of paranasal
sinuses are expected to fuel the growth prospects of chronic rhinosinusitis market
in the forecast period.
To get holistic FREE SAMPLE of the report, please click: https://www.emergenresearch.com/request-sample-form/74
Roughly
more than 15 million people suffer from chronic symptoms of rhinosinusitis in
the United States, that is, prevalence of chronic rhinosinusitis ranges from 1%
to 5% of the total US population. Chronic rhinosinusitis is primarily
characterized by nasel blockage, inflammation of the sinus and nasel linings,
facial pain along with rhinorrhea and loss of sense of smell. Effective
treatment includes improvement in sinus outflow, enhancement of mucociliary
clearance and elimination of inflammation and local infection among other
associated treatments.
Additionally,
increase in implementation of minimally invasive surgical procedures,
widespread awareness concerning the symptoms of the target disease across
regions and technological progressions among other favorable scenarios are
likely to augment the growth of industry during the period of 2020-2027.
However, low preference towards sinus surgical undertakings, post-surgery risks
of sinus treatment and high cost of treatment may hinder the growth of chronic
rhinosinusitis market in the forecast period.
The leading manufactures in
the market include Agilent Technologies, Bio-Rad Laboratories, Inc., BGI; Biomatters
Ltd., Congenica Ltd, Eurofins Scientific, DNASTAR, F. Hoffmann-La Roche Ltd.,
Genomatix GmbH, Thermo Fisher Scientific, and Foundation Medicine, among
others, among others.
Browse complete report description and
visit our website @ https://www.emergenresearch.com/industry-report/chronic-rhinosinusitis-market
Regional Scope: North America; Europe; Asia Pacific; Central
& South America; MEA
Product Outlook (Revenue in Million USD;
2017–2027)
- Steroids
- Topical Nasal Steroid
- Systemic Steroids
- Nasal Irrigation
- Hypertonic and Isotonic Saline
- Steroid Nasal Irrigation
- Topical Antibiotic Therapy
- Surgical Based
- Ethmoidectomy
- Endoscopic Intranasal Intervention
- Others
- Antibiotics
- Amoxicillin-Clavulanate
- Clindamycin
- Sulfamethoxazole
- Levofloxacin
- Macrolide Therapy
- Antifungal Therapy
Disease Outlook (Revenue in Million USD;
2017–2027)
- Anatomical Differences
- Nasal Tumors
- Mucosal Edema
- Non-Allergic Rhinitis
- Immune Deficiency
- Other
Distribution Channel (Revenue in Million
USD; 2017–2027)
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Other
North America accounted for the largest market share of
approximately, 37.2% in the global chronic rhinosinusitis market in 2019
primarily due to growing incidences of chronic asthma and rhinosinusitis
symptoms along with competent infrastructure and favorable reimbursement
scenarios. Owing to such promising market drivers, the North American market is
anticipated to grow significantly through the forecast period.
Interested in this report?
Get your FREE sample now! https://www.emergenresearch.com/request-sample-form/74
Chapter 1. Methodology
& Sources
1.1. Market
Definition
1.2. Research
Scope
1.3. Methodology
1.4. Research
Sources
1.4.1.
Primary
1.4.2.
Secondary
1.4.3. Paid
Sources
1.5. Market
Estimation Technique
Chapter 2. Executive
Summary
2.1. Summary
Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Chronic
Rhinosinusitis Market Segmentation & Impact Analysis
4.1. Chronic
Rhinosinusitis Market Material Segmentation Analysis
4.2. Industrial
Outlook
4.2.1.
Market indicators analysis
4.2.2.
Market drivers analysis
4.2.2.1. Intensifying Prevalence of rhinosinusitis
4.2.2.2. Emergence of efficient therapeutics for Chronic rhinosinusitis
4.2.2.3. Favorable reimbursements
4.2.3.
Market restraints analysis
4.2.3.1. High cost of treatment
4.2.3.2. Side effects associated with the treatment/surgery
4.3. Technological
Insights
4.4. Clinical
Pipeline Analysis
4.5. Regulatory
Framework
4.6. Porter’s Five
Forces Analysis
4.7. Competitive
Metric Space Analysis
4.8. Price trend
Analysis
4.9. Covid-19
Impact Analysis
Chapter 5. Chronic
Rhinosinusitis Market By Product Type Insights & Trends, Revenue (USD
Million)
5.1. Product Type
Dynamics & Market Share, 2019 & 2027
5.1.1.
Steroids
5.1.2. Nasel
irrigation
5.1.3. Surgical Based
5.1.4.
Antibiotics
5.1.5.
Macrolide Therapy
5.1.6. Antifungal Therapy
Chapter 6. Chronic
Rhinosinusitis Market By Disease Insights & Trends Revenue (USD Million)
6.1. Disease
Dynamics & Market Share, 2019 & 2027
6.1.1.
Anatomical Differences
6.1.2. Nasal
Tumors
6.1.3.
Mucosal Edema
6.1.4.
Non-Allergic Rhinitis
6.1.5.
Immune Deficiency
6.1.6. Other
Continue…
Thank you for reading our report. For further information or
queries about the report or customization options, please get in touch with us.
We will ensure your report is tailored according to your requirements.
Comments
Post a Comment